Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis

Saved in:
Bibliographic Details
Main Authors: Aqieda Bayat, MD, Ankit Agrawal, MD, Ashwin Kumar, MD, Muhammad Majid, MD, Beni Verma, MD, Abdullah Yesilyaprak, MD, Allan L. Klein, MD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:JACC: Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X24007178
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846121129102540800
author Aqieda Bayat, MD
Ankit Agrawal, MD
Ashwin Kumar, MD
Muhammad Majid, MD
Beni Verma, MD
Abdullah Yesilyaprak, MD
Allan L. Klein, MD
author_facet Aqieda Bayat, MD
Ankit Agrawal, MD
Ashwin Kumar, MD
Muhammad Majid, MD
Beni Verma, MD
Abdullah Yesilyaprak, MD
Allan L. Klein, MD
author_sort Aqieda Bayat, MD
collection DOAJ
format Article
id doaj-art-dbf1ec7bdbd04d6b8127ce211292f5a7
institution Kabale University
issn 2772-963X
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series JACC: Advances
spelling doaj-art-dbf1ec7bdbd04d6b8127ce211292f5a72024-12-16T05:39:10ZengElsevierJACC: Advances2772-963X2025-01-0141101437Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent PericarditisAqieda Bayat, MD0Ankit Agrawal, MD1Ashwin Kumar, MD2Muhammad Majid, MD3Beni Verma, MD4Abdullah Yesilyaprak, MD5Allan L. Klein, MD6Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USACenter for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USACenter for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USACenter for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USACenter for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USACenter for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USAAddress for correspondence: Dr Allan L. Klein, Center for the Diagnosis and Treatment of Pericardial Diseases, Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J1-5 Cleveland, Ohio 44195, USA.; Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USAhttp://www.sciencedirect.com/science/article/pii/S2772963X24007178lipidsrecurrent pericarditisrilonacept
spellingShingle Aqieda Bayat, MD
Ankit Agrawal, MD
Ashwin Kumar, MD
Muhammad Majid, MD
Beni Verma, MD
Abdullah Yesilyaprak, MD
Allan L. Klein, MD
Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
JACC: Advances
lipids
recurrent pericarditis
rilonacept
title Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
title_full Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
title_fullStr Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
title_full_unstemmed Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
title_short Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis
title_sort assessing the impact of rilonacept on lipid profiles in patients with recurrent pericarditis
topic lipids
recurrent pericarditis
rilonacept
url http://www.sciencedirect.com/science/article/pii/S2772963X24007178
work_keys_str_mv AT aqiedabayatmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT ankitagrawalmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT ashwinkumarmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT muhammadmajidmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT benivermamd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT abdullahyesilyaprakmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis
AT allanlkleinmd assessingtheimpactofrilonaceptonlipidprofilesinpatientswithrecurrentpericarditis